ZA889441B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA889441B ZA889441B ZA889441A ZA889441A ZA889441B ZA 889441 B ZA889441 B ZA 889441B ZA 889441 A ZA889441 A ZA 889441A ZA 889441 A ZA889441 A ZA 889441A ZA 889441 B ZA889441 B ZA 889441B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- present
- esters
- cimetidine
- bioavailability
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000002148 esters Chemical class 0.000 abstract 2
- 239000007910 chewable tablet Substances 0.000 abstract 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract 1
- 229960001380 cimetidine Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 150000002314 glycerols Chemical class 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000003979 granulating agent Substances 0.000 abstract 1
- 235000019629 palatability Nutrition 0.000 abstract 1
- 239000008193 pharmaceutical granule composition Substances 0.000 abstract 1
- 239000006068 taste-masking agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878730011A GB8730011D0 (en) | 1987-12-23 | 1987-12-23 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA889441B true ZA889441B (en) | 1989-12-27 |
Family
ID=10628958
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA889441A ZA889441B (en) | 1987-12-23 | 1988-12-19 | Pharmaceutical compositions |
Country Status (15)
Country | Link |
---|---|
US (1) | US5057319A (da) |
EP (1) | EP0322048B1 (da) |
JP (1) | JP2840097B2 (da) |
AT (1) | ATE77236T1 (da) |
AU (1) | AU605671B2 (da) |
CA (1) | CA1313140C (da) |
DE (1) | DE3872199T2 (da) |
DK (1) | DK415689A (da) |
ES (1) | ES2042723T3 (da) |
GB (1) | GB8730011D0 (da) |
GR (1) | GR3005640T3 (da) |
IE (1) | IE60966B1 (da) |
PT (1) | PT89260B (da) |
WO (1) | WO1989005640A1 (da) |
ZA (1) | ZA889441B (da) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5578322A (en) * | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
US5629013A (en) * | 1991-04-04 | 1997-05-13 | The Procter & Gamble Company | Chewable calcium carbonate antacid tablet compositions |
ATE245023T1 (de) * | 1991-05-28 | 2003-08-15 | Mcneil Ppc Inc | Kaubare zusammensetzung zur arzneimittelfreisetzung |
US5380535A (en) * | 1991-05-28 | 1995-01-10 | Geyer; Robert P. | Chewable drug-delivery compositions and methods for preparing the same |
GB9127150D0 (en) * | 1991-12-20 | 1992-02-19 | Smithkline Beecham Plc | Novel treatment |
EP0663818A4 (en) * | 1992-09-03 | 1996-04-24 | Ibah Inc | TASTE-COVERING PHARMACEUTICAL SUMMARY AND METHOD FOR PRODUCING THE SAME. |
JPH08510989A (ja) * | 1992-10-16 | 1996-11-19 | グラクソ、グループ、リミテッド | ラニチジン組成物 |
GB9224855D0 (en) * | 1992-11-27 | 1993-01-13 | Smithkline Beecham Plc | Pharmaceutical compositions |
AU5681294A (en) * | 1992-11-30 | 1994-06-22 | Kv Pharmaceutical Company | Tastemasked pharmaceutical materials |
US5622980A (en) * | 1993-08-17 | 1997-04-22 | Applied Analytical Industries, Inc. | Oral compositions of H2-antagonists |
JP3601071B2 (ja) * | 1994-03-11 | 2004-12-15 | 不二製油株式会社 | ブルーム防止剤並びにこれを含有するラウリン系油脂及びチョコレート類 |
AUPN862596A0 (en) * | 1996-03-12 | 1996-04-04 | F.H. Faulding & Co. Limited | Pharmaceutical compositions |
US6537525B1 (en) * | 1997-01-29 | 2003-03-25 | Douglas H. West | Medicated chewing-gum |
KR20010030798A (ko) * | 1997-09-30 | 2001-04-16 | 스즈키 다다시 | 경구 투여 제제 |
US5891476A (en) * | 1997-12-22 | 1999-04-06 | Reo; Joe P. | Tastemasked pharmaceutical system |
FR2784895B1 (fr) * | 1998-10-23 | 2004-12-17 | Gattefosse Ets Sa | Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
WO2002030400A1 (fr) | 2000-10-06 | 2002-04-18 | Takeda Chemical Industries, Ltd. | Preparations solides |
US20040115287A1 (en) * | 2002-12-17 | 2004-06-17 | Lipocine, Inc. | Hydrophobic active agent compositions and methods |
US7282217B1 (en) | 2003-08-29 | 2007-10-16 | Kv Pharmaceutical Company | Rapidly disintegrable tablets |
AU2007295178B2 (en) * | 2006-09-15 | 2013-04-18 | Echo Pharmaceuticals B.V. | Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture |
AU2007295179B2 (en) * | 2006-09-15 | 2013-05-30 | Echo Pharmaceuticals B.V. | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
US9375437B2 (en) | 2010-06-18 | 2016-06-28 | Lipocine Inc. | Progesterone containing oral dosage forms and kits |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
US8951996B2 (en) | 2011-07-28 | 2015-02-10 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
US20170035781A1 (en) | 2015-06-22 | 2017-02-09 | Lipocine Inc. | 17-hydroxyprogesterone ester-containing oral compositions and related methods |
US20180147215A1 (en) | 2016-11-28 | 2018-05-31 | Lipocine Inc. | Oral testosterone undecanoate therapy |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3308217A (en) * | 1965-02-09 | 1967-03-07 | Lowy Lawrence | Method of granulating materials for subsequent forming into tablets |
FR2253507A1 (en) * | 1973-12-11 | 1975-07-04 | Houdet Antoine | Vincamine administration using delayed release excipient - allowing prolonged action |
US4256108A (en) * | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
JPS6029682B2 (ja) * | 1980-07-11 | 1985-07-12 | 山之内製薬株式会社 | 苦味のない製剤用組成物およびその製造法 |
MTP930B (en) * | 1982-04-30 | 1984-04-10 | Delandale Labs Ltd | Substained release lithium-containing tablets and method for their manufacture |
US4851228A (en) * | 1984-06-20 | 1989-07-25 | Merck & Co., Inc. | Multiparticulate controlled porosity osmotic |
US4755387A (en) * | 1985-03-21 | 1988-07-05 | The Procter & Gamble Company | Therapeutic particles |
DE3524003A1 (de) * | 1985-07-04 | 1987-01-08 | Heumann Ludwig & Co Gmbh | Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung |
FR2593065B1 (fr) * | 1986-01-22 | 1988-09-09 | Smith Kline French Lab | Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation. |
US4786502A (en) * | 1986-10-06 | 1988-11-22 | The Procter & Gamble Company | Palatable solid pharmaceutical compositions |
GB2195890A (en) * | 1986-10-06 | 1988-04-20 | Procter & Gamble | Improving palatability of pharmaceutical chewable tablets |
GB2195891A (en) * | 1986-10-06 | 1988-04-20 | Procter & Gamble | Improving palatability of pharmaceutical chewable tablets |
US4892778A (en) * | 1987-05-27 | 1990-01-09 | Alza Corporation | Juxtaposed laminated arrangement |
US4824675A (en) * | 1987-07-13 | 1989-04-25 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
US4814183A (en) * | 1987-08-31 | 1989-03-21 | Merck & Co., Inc. | Device for the controlled release of drugs with Donnan-like modulation by charged insoluble resins |
ATE82680T1 (de) * | 1988-05-04 | 1992-12-15 | Smith Kline French Lab | Kautablette. |
-
1987
- 1987-12-23 GB GB878730011A patent/GB8730011D0/en active Pending
-
1988
- 1988-12-16 DE DE8888202909T patent/DE3872199T2/de not_active Expired - Lifetime
- 1988-12-16 AT AT88202909T patent/ATE77236T1/de not_active IP Right Cessation
- 1988-12-16 WO PCT/EP1988/001189 patent/WO1989005640A1/en unknown
- 1988-12-16 JP JP1501032A patent/JP2840097B2/ja not_active Expired - Lifetime
- 1988-12-16 ES ES88202909T patent/ES2042723T3/es not_active Expired - Lifetime
- 1988-12-16 AU AU29157/89A patent/AU605671B2/en not_active Expired
- 1988-12-16 EP EP88202909A patent/EP0322048B1/en not_active Expired - Lifetime
- 1988-12-19 ZA ZA889441A patent/ZA889441B/xx unknown
- 1988-12-19 PT PT89260A patent/PT89260B/pt not_active IP Right Cessation
- 1988-12-20 US US07/287,194 patent/US5057319A/en not_active Expired - Lifetime
- 1988-12-22 IE IE384388A patent/IE60966B1/en not_active IP Right Cessation
- 1988-12-22 CA CA000586773A patent/CA1313140C/en not_active Expired - Lifetime
-
1989
- 1989-08-23 DK DK415689A patent/DK415689A/da not_active Application Discontinuation
-
1992
- 1992-09-07 GR GR920401972T patent/GR3005640T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE883843L (en) | 1989-06-23 |
GB8730011D0 (en) | 1988-02-03 |
PT89260A (pt) | 1989-12-29 |
CA1313140C (en) | 1993-01-26 |
EP0322048A1 (en) | 1989-06-28 |
ES2042723T3 (es) | 1993-12-16 |
PT89260B (pt) | 1993-07-30 |
IE60966B1 (en) | 1994-09-07 |
DK415689D0 (da) | 1989-08-23 |
DK415689A (da) | 1989-08-23 |
JP2840097B2 (ja) | 1998-12-24 |
US5057319A (en) | 1991-10-15 |
EP0322048B1 (en) | 1992-06-17 |
JPH02502729A (ja) | 1990-08-30 |
WO1989005640A1 (en) | 1989-06-29 |
GR3005640T3 (da) | 1993-06-07 |
DE3872199D1 (de) | 1992-07-23 |
AU2915789A (en) | 1989-07-19 |
ATE77236T1 (de) | 1992-07-15 |
AU605671B2 (en) | 1991-01-17 |
DE3872199T2 (de) | 1992-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA889441B (en) | Pharmaceutical compositions | |
IE881368L (en) | Pharmaceutical compositions | |
CA2158630A1 (en) | Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability | |
EP0103387A3 (en) | Long-acting matrix tablet formulations | |
IT1221012B (it) | Polimeri caricati con farmaci con migliorate solubilita' e biodisponibilita',procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
PL299870A1 (en) | 7-beta-[(z)-2-(2-amino-4-thiasolyl)-2-hydroxyiminoacetamide]-3-(1,2,3-triazol-4-yl)-thiomethylothio-3-cephemo-4-carboxylic hydrochloride, crystalline hydrate of 7-beta-[(z)-2-(2-amino-4-thiasolyl)-2-hydroxyiminoacetamide]-3-(1,2,3-triazol-4-yl)-thiomethylothio-3-cephemo-4-carboxylic hydrochloride, method of obtaining these compounds, pharmaceutical preparation and method of fighting against bacteriae | |
ES2086011T3 (es) | Chicle farmaceutico con acido acetilsalicilico. | |
JPS56110612A (en) | Readily disintegrable and absorbable compression molded article of slightly soluble drug | |
DE3766200D1 (de) | L-dopa enthaltendes arzneimittel. | |
IT8522493A0 (it) | Ottenute. procedimento per la preparazione di compresse, anche a rilascio prolungato, di isosorbide-5-mononitrato stabilizzato e formulazioni cosi' | |
IT1235053B (it) | Metodi per la preparazione di composizioni farmaceutiche a base di bromocriptina dotate di elevata stabilita' e prodotti derivanti. | |
ZA898331B (en) | Pharmaceutical compositions | |
AU4730689A (en) | Microgranulates comprising a saturated fatty acid triglyceride and an active substance, and topical pharmaceutical compositions containing such microgranulates | |
HUT66238A (en) | Bicyclic carboxylic acid derivatives, pharmaceutical compositions contg. them as active agent and process to prepare them | |
HUT61024A (en) | Process for producing 10(1-hydroxyethyl)-11-oxo-1-aza-tricyclo/7.2.0.0.3.8/undex-2-ene-2-carboxylic acid esters and pharmaceutical compositions comprising same as active ingredient | |
GB2021409A (en) | Pharmaceutical composition | |
IE831863L (en) | Fatty acid compositions. | |
HUT54166A (en) | Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
IE56229B1 (en) | 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them | |
DE69209916D1 (de) | Oral anzuwendende Arzneimittel Dapiprazol enthaltend | |
IT8720438A0 (it) | Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato, loro procedimento di preparazione e loro composizioni farmaceutiche. | |
CA2136071A1 (en) | 2-arylpropionic acid compositions and process for preparing the same | |
EP0351876A3 (en) | Composition for potentiating vaccination effect | |
EP0383481A3 (en) | Anesthetic oral compositions | |
HUT53121A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient |